Guillermo Fernandez-Varo

Summary

Publications

  1. doi request reprint [Serological markers of fibrosis]
    Guillermo Fernandez-Varo
    Servicio de Bioquímica y Genética Molecular, Hospital Clinic, Departamento de Fisiología I, Facultad de Medicina, Universidad de Barcelona, Barcelona, Espana
    Gastroenterol Hepatol 35:10-6. 2012
  2. pmc Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis
    Toni Segovia-Silvestre
    Nordic Bioscience A S, Herlev, Denmark
    Fibrogenesis Tissue Repair 4:19. 2011
  3. doi request reprint ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study
    Gonzalo Crespo
    Liver Unit, Hospital Clinic, CIBERehd, IDIBAPS, Barcelona, Spain
    J Hepatol 57:281-7. 2012
  4. doi request reprint Factors involved in extracellular matrix turnover in human derived cardiomyocytes
    Gregori Casals
    Service of Biochemistry and Molecular Genetics, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Cell Physiol Biochem 32:1125-36. 2013
  5. doi request reprint Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation
    José A Carrión
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, CIBERehd, Barcelona, Spain
    Gastroenterology 138:147-58.e1. 2010
  6. doi request reprint Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems
    Vedrana Reichenbach
    Service of Biochemistry and Molecular Genetics, Hospital Clinic, Barcelona, Spain
    J Pharmacol Exp Ther 340:629-37. 2012

Collaborators

  • Juan Carlos Garcia-Pagan
  • José A Carrión
  • Zoe Mariñó
  • Gregori Casals
  • Vedrana Reichenbach
  • Wladimiro Jimenez
  • Manuel Morales-Ruiz
  • Pedro Melgar-Lesmes
  • Gonzalo Crespo
  • Toni Segovia-Silvestre
  • Santi Marfà
  • Xavier Forns
  • Miquel Navasa
  • Alexandros Makriyannis
  • Rosa Miquel
  • Teresa Campos
  • Josefa Ros
  • Rosa Gilabert
  • Stella M Martinez
  • Efstathios Vassiliadis
  • Natasha Barascuk
  • Morten A Karsdal

Detail Information

Publications6

  1. doi request reprint [Serological markers of fibrosis]
    Guillermo Fernandez-Varo
    Servicio de Bioquímica y Genética Molecular, Hospital Clinic, Departamento de Fisiología I, Facultad de Medicina, Universidad de Barcelona, Barcelona, Espana
    Gastroenterol Hepatol 35:10-6. 2012
    ..The present article reviews the most widely discussed noninvasive markers, the most recent alternatives, and the perspectives for their use in clinical practice...
  2. pmc Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis
    Toni Segovia-Silvestre
    Nordic Bioscience A S, Herlev, Denmark
    Fibrogenesis Tissue Repair 4:19. 2011
    ..abstract:..
  3. doi request reprint ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study
    Gonzalo Crespo
    Liver Unit, Hospital Clinic, CIBERehd, IDIBAPS, Barcelona, Spain
    J Hepatol 57:281-7. 2012
    ..Our aim was to evaluate a serologic marker (ELF) and two ultrasound-based methods (FibroScan and ARFI), as well as their combinations, in the assessment of liver fibrosis...
  4. doi request reprint Factors involved in extracellular matrix turnover in human derived cardiomyocytes
    Gregori Casals
    Service of Biochemistry and Molecular Genetics, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer IDIBAPS, Barcelona, Spain
    Cell Physiol Biochem 32:1125-36. 2013
    ..The molecular mechanisms by which myocardial ischemia translates into ventricular remodeling remain unclear...
  5. doi request reprint Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation
    José A Carrión
    Liver Unit, Institut de Malalties Digestives, Hospital Clinic, Institut d Investigacions Biomediques August Pi i Sunyer, CIBERehd, Barcelona, Spain
    Gastroenterology 138:147-58.e1. 2010
    ..This study evaluated whether serum fibrosis markers can predict hepatitis C recurrence during the first year after liver transplantation...
  6. doi request reprint Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems
    Vedrana Reichenbach
    Service of Biochemistry and Molecular Genetics, Hospital Clinic, Barcelona, Spain
    J Pharmacol Exp Ther 340:629-37. 2012
    ..The mechanisms underlying these phenomena are coincident despite the marked dissimilarities between the CB2 and APJ signaling pathways, thus opening new avenues for preventing fibrosis progression in liver diseases...